Showing results (251-260 of 566) with videos related to
Sort By:
Pageof 57
Rheumatology (Oxford, England)|February 16, 2021
Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPAREVibeke Strand, Namita Tundia, Martin Bergman, et al.Annals of the Rheumatic Diseases|March 26, 2013
Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trialsVibeke Strand, Roger A Levy, Ricard Cervera, et al.The Journal of Rheumatology|June 2, 2004
Variability of precision in scoring radiographic abnormalities in rheumatoid arthritis by experienced readersJohn T Sharp, Frederick Wolfe, Marissa Lassere, et al.RMD Open|June 7, 2019
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb studyFrank Buttgereit, Vibeke Strand, Eun Bong Lee, et al.Journal of Comparative Effectiveness Research|February 27, 2019
Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritisVibeke Strand, Iain McInnes, Philip Mease, et al.Rheumatology (Oxford, England)|March 2, 2016
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritisVibeke Strand, Ronald F van Vollenhoven, Eun Bong Lee, et al.Annals of the Rheumatic Diseases|March 11, 2016
The changing landscape of biosimilars in rheumatologyThomas Dörner, Vibeke Strand, Paul Cornes, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 15, 2017
Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic ReviewVibeke Strand, Alejandro Balsa, Jamal Al-Saleh, et al.The Journal of Rheumatology. Supplement|June 2, 2004
Lefunomide in combination therapyJoachim R Kalden, Josef S Smolen, Paul Emery, et al.The Journal of Rheumatology. Supplement|June 2, 2004
The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapyJosef S Smolen, Paul Emery, Joachim R Kalden, et al.Pageof 57